Brandywine Global Investment Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Brandywine Global Investment Management’s Portfolio MGCD Stock Details MGCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-44,200	Closed	-$488K	–	981
2017 Q4	$488K	Hold	44,200	–	–	﹤0.01%	617
2017 Q3	$397K	Hold	44,200	–	–	﹤0.01%	630
2017 Q2	$363K	Hold	44,200	–	–	﹤0.01%	642
2017 Q1	$370K	Buy	44,200 +21,000	+91%	+$185K	﹤0.01%	638
2016 Q4	$184K	Buy	+23,200	New	+$173K	﹤0.01%	722

Brandywine Global Investment Management's MGCD Position: Q1 2018 in Review

Brandywine Global Investment Management sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 44,200 shares — an estimated $488K sold.

Brandywine Global Investment Management first reported a position in MGCD in Q4 2016 and held it in 5 quarters. The position peaked at $488K in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.

Brandywine Global Investment Management reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
Brandywine Global Investment Management sold 44,200 MGC Diagnostics Corporation shares in Q1 2018, an estimated $488K.
Brandywine Global Investment Management first reported a position in MGC Diagnostics Corporation in Q4 2016 and held it in 5 quarters.
Brandywine Global Investment Management's MGC Diagnostics Corporation position peaked at $488K in Q4 2017.
0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.

Based on Brandywine Global Investment Management's 13F filing for Q1 2018, filed 15 May 2018.